INVO logo

INVO Bioscience (INVO) EBITDA

Annual EBITDA

-$6.88 M
+$3.87 M+36.02%

December 31, 2023

Summary

Performance

1-Year Change

+36.02%

3-Year Change

-25.63%

5-Year Change

-161.71%

15-Year Change

-914%

INVO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$323.60 K
INVO annual EBITDA is currently -2226.08% below its historical high of $323.60 thousand

3-Year Low

-$10.75 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
INVO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
INVO next annual earnings announcement has not yet been scheduled

OtherINVOprofitabilitymetrics:

Annual Revenue

$3.02 M
INVO annual revenue is $3.02 million

Annual Net Income

-$8.03 M
INVO annual net profit is -$8.03 million

Annual EBIT

-$7.08 M
INVO annual earnings before interest & taxes is -$7.08 million

Annual EPS

-$5.13
INVO annual earnings per share is -$5.13

Quarterly EBITDA

-$1.10 M
+$547.92 K+33.30%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+7.51%

3-Year Change

+59.37%

5-Year Change

+59.37%

INVO Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$928.40 K
INVO quarterly EBITDA is currently -218.19% below its historical high of $928.40 thousand

3-Year Low

-$2.80 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
INVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
INVO next earnings announcement has not yet been scheduled

OtherINVOprofitabilitymetrics:

Quarterly Revenue

$1.43 M
INVO quarterly revenue is $1.43 million

Quarterly Net Income

-$1.63 M
INVO quarterly net profit is -$1.63 million

Quarterly EBIT

-$1.33 M
INVO quarterly earnings before interest & taxes is -$1.33 million

Quarterly EPS

-$0.42
INVO quarterly earnings per share is -$0.42

TTM EBITDA

-$5.58 M
-$223.28 K-4.17%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+3.03%

3-Year Change

+12.43%

5-Year Change

+12.43%

INVO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.09 M
INVO TTM EBITDA is currently -610.90% below its historical high of $1.09 million

3-Year Low

-$10.72 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
INVO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
INVO next earnings announcement has not yet been scheduled

OtherINVOprofitabilitymetrics:

TTM Revenue

$6.23 M
INVO TTM revenue is $6.23 million

TTM Net Income

-$7.47 M
INVO TTM net profit is -$7.47 million

TTM EBIT

-$6.41 M
INVO TTM earnings before interest & taxes is -$6.41 million

TTM EPS

-$2.26
INVO TTM earnings per share is -$2.26

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$6.88 M
INVO annual EBITDA is -$6.88 million

Annual Net Income

-$8.03 M
INVO annual net profit is -$8.03 million

Annual Interest Expense

$925.90 K
INVO annual interest expense is $925.90 thousand

Annual Income Tax

$27.80 K
INVO annual income tax is $27.80 thousand

Annual D&A

$200.90 K
INVO annual depreciation & amortization is $200.90 thousand

INVO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+36.0%+7.5%+3.0%
3 y3 years-25.6%+59.4%+12.4%
5 y5 years-161.7%+59.4%+12.4%

INVO EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+31.8%+56.3%-398.5%+155.2%+6.9%+92.2%
5 y5-year+292.2%+56.3%-398.5%+155.2%+218.0%+92.2%
alltimeall time-2226.1%+56.3%-218.2%+304.5%-610.9%+92.2%

INVO Bioscience EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.10 M(-33.3%)
-$5.58 M(+4.2%)
Jun 2024
-
-$1.65 M(+38.7%)
-$5.35 M(-6.9%)
Mar 2024
-
-$1.19 M(-28.0%)
-$5.75 M(-16.4%)
Dec 2023
-$6.88 M(-36.0%)
-$1.65 M(+88.6%)
-$6.88 M(-13.1%)
Sep 2023
-
-$874.00 K(-57.2%)
-$7.92 M(-17.3%)
Jun 2023
-
-$2.04 M(-11.8%)
-$9.57 M(-7.3%)
Mar 2023
-
-$2.32 M(-13.9%)
-$10.33 M(-3.6%)
Dec 2022
-$10.75 M(+106.0%)
-$2.69 M(+6.4%)
-$10.72 M(+39.9%)
Sep 2022
-
-$2.53 M(-9.7%)
-$7.66 M(+2.5%)
Jun 2022
-
-$2.80 M(+3.7%)
-$7.47 M(+17.4%)
Mar 2022
-
-$2.70 M(-834.6%)
-$6.37 M(+22.1%)
Dec 2021
-$5.22 M(-4.7%)
$367.60 K(-115.7%)
-$5.22 M(-29.1%)
Sep 2021
-
-$2.34 M(+38.2%)
-$7.36 M(+17.2%)
Jun 2021
-
-$1.69 M(+9.3%)
-$6.28 M(+11.4%)
Mar 2021
-
-$1.55 M(-12.7%)
-$5.64 M(+3.0%)
Dec 2020
-$5.48 M(+212.2%)
-$1.77 M(+41.0%)
-$5.48 M(+23.8%)
Sep 2020
-
-$1.26 M(+19.4%)
-$4.42 M(+16.8%)
Jun 2020
-
-$1.05 M(-24.0%)
-$3.79 M(+35.6%)
Mar 2020
-
-$1.39 M(+92.0%)
-$2.79 M(+59.3%)
Dec 2019
-$1.75 M(-33.3%)
-$723.00 K(+16.0%)
-$1.75 M(+13.7%)
Sep 2019
-
-$623.20 K(+926.7%)
-$1.54 M(+39.2%)
Jun 2019
-
-$60.70 K(-82.5%)
-$1.11 M(-60.9%)
Mar 2019
-
-$347.10 K(-32.2%)
-$2.84 M(+7.9%)
Dec 2018
-$2.63 M(+287.5%)
-$511.90 K(+171.6%)
-$2.63 M(+13.7%)
Sep 2018
-
-$188.50 K(-89.5%)
-$2.31 M(+2.0%)
Jun 2018
-
-$1.79 M(+1186.3%)
-$2.27 M(+271.6%)
Mar 2018
-
-$139.10 K(-28.9%)
-$610.00 K(-10.1%)
Dec 2017
-$678.50 K(-67.8%)
-$195.60 K(+36.9%)
-$678.50 K(-9.9%)
Sep 2017
-
-$142.90 K(+7.9%)
-$753.20 K(-7.9%)
Jun 2017
-
-$132.40 K(-36.2%)
-$817.70 K(-61.7%)
Mar 2017
-
-$207.60 K(-23.2%)
-$2.14 M(+1.3%)
DateAnnualQuarterlyTTM
Dec 2016
-$2.11 M(-57.2%)
-$270.30 K(+30.3%)
-$2.11 M(+1.7%)
Sep 2016
-
-$207.40 K(-85.7%)
-$2.07 M(+4.5%)
Jun 2016
-
-$1.45 M(+709.6%)
-$1.98 M(-60.1%)
Mar 2016
-
-$179.30 K(-23.9%)
-$4.97 M(+1.0%)
Dec 2015
-$4.92 M(+194.7%)
-$235.60 K(+100.7%)
-$4.92 M(+5.0%)
Sep 2015
-
-$117.40 K(-97.4%)
-$4.69 M(+2.6%)
Jun 2015
-
-$4.44 M(+3303.5%)
-$4.57 M(+3403.5%)
Mar 2015
-
-$130.40 K(-33.6%)
-$130.40 K(-79.0%)
Dec 2014
-$1.67 M(+139.5%)
-
-
Dec 2013
-$697.30 K(+24.1%)
-
-
Dec 2012
-$562.00 K(-9.4%)
-
-
Dec 2011
-$620.40 K(-291.7%)
-$196.50 K(+189.4%)
-$620.80 K(-6.2%)
Sep 2011
-
-$67.90 K(-64.3%)
-$661.50 K(-12.7%)
Jun 2011
-
-$190.00 K(+14.2%)
-$757.60 K(+14.4%)
Mar 2011
-
-$166.40 K(-29.8%)
-$662.40 K(-253.2%)
Dec 2010
$323.60 K(-124.5%)
-$237.20 K(+44.6%)
$432.40 K(-60.4%)
Sep 2010
-
-$164.00 K(+73.0%)
$1.09 M(+86.7%)
Jun 2010
-
-$94.80 K(-110.2%)
$584.70 K(+134.4%)
Mar 2010
-
$928.40 K(+120.0%)
$249.40 K(-118.9%)
Dec 2009
-$1.32 M(-28.7%)
$422.00 K(-162.9%)
-$1.32 M(-62.9%)
Sep 2009
-
-$670.90 K(+56.0%)
-$3.56 M(+23.2%)
Jun 2009
-
-$430.10 K(-33.0%)
-$2.89 M(+5.7%)
Mar 2009
-
-$642.20 K(-64.7%)
-$2.74 M(+29.6%)
Dec 2008
-$1.85 M(+7375.8%)
-$1.82 M(>+9900.0%)
-$2.11 M(+592.5%)
Sep 2008
-
-$100.00(-100.0%)
-$305.10 K(-0.4%)
Jun 2008
-
-$274.00 K(+1439.3%)
-$306.30 K(+576.2%)
Mar 2008
-
-$17.80 K(+34.8%)
-$45.30 K(+47.6%)
Dec 2007
-$24.80 K(+1450.0%)
-$13.20 K(+915.4%)
-$30.70 K(+75.4%)
Sep 2007
-
-$1300.00(-90.0%)
-$17.50 K(+8.0%)
Jun 2007
-
-$13.00 K(+306.3%)
-$16.20 K(+406.3%)
Mar 2007
-
-$3200.00
-$3200.00
Dec 2006
-$1600.00
-
-

FAQ

  • What is INVO Bioscience annual EBITDA?
  • What is the all time high annual EBITDA for INVO Bioscience?
  • What is INVO Bioscience annual EBITDA year-on-year change?
  • What is INVO Bioscience quarterly EBITDA?
  • What is the all time high quarterly EBITDA for INVO Bioscience?
  • What is INVO Bioscience quarterly EBITDA year-on-year change?
  • What is INVO Bioscience TTM EBITDA?
  • What is the all time high TTM EBITDA for INVO Bioscience?
  • What is INVO Bioscience TTM EBITDA year-on-year change?

What is INVO Bioscience annual EBITDA?

The current annual EBITDA of INVO is -$6.88 M

What is the all time high annual EBITDA for INVO Bioscience?

INVO Bioscience all-time high annual EBITDA is $323.60 K

What is INVO Bioscience annual EBITDA year-on-year change?

Over the past year, INVO annual EBITDA has changed by +$3.87 M (+36.02%)

What is INVO Bioscience quarterly EBITDA?

The current quarterly EBITDA of INVO is -$1.10 M

What is the all time high quarterly EBITDA for INVO Bioscience?

INVO Bioscience all-time high quarterly EBITDA is $928.40 K

What is INVO Bioscience quarterly EBITDA year-on-year change?

Over the past year, INVO quarterly EBITDA has changed by +$89.12 K (+7.51%)

What is INVO Bioscience TTM EBITDA?

The current TTM EBITDA of INVO is -$5.58 M

What is the all time high TTM EBITDA for INVO Bioscience?

INVO Bioscience all-time high TTM EBITDA is $1.09 M

What is INVO Bioscience TTM EBITDA year-on-year change?

Over the past year, INVO TTM EBITDA has changed by +$174.22 K (+3.03%)